Sertraline


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000568 Amenorrhea PMID:17414262
MESH:D001145 Arrhythmias, Cardiac PMID:11485134
MESH:D001480 Basal Ganglia Diseases PMID:11869410; PMID:9723116
MESH:D001714 Bipolar Disorder PMID:11531662; PMID:12807380; PMID:8185011
MESH:D001929 Brain Edema PMID:19782326
MESH:D002389 Catatonia PMID:9742515
MESH:D003128 Coma PMID:19845549
MESH:D003221 Confusion PMID:9048728
MESH:D003693 Delirium PMID:8659626
MESH:D003704 Dementia PMID:12839368
MESH:D003866 Depressive Disorder PMID:12586234; PMID:15708425
MESH:D003967 Diarrhea PMID:10363731; PMID:10732656; PMID:9048728; PMID:9448656
MESH:D004213 Dissociative Disorders PMID:12724468
MESH:D004244 Dizziness PMID:8840377
MESH:D004401 Dysarthria PMID:11816261
MESH:D004421 Dystonia PMID:9004068; PMID:9010129; PMID:9934951
MESH:D004830 Epilepsy, Tonic-Clonic PMID:9256580
MESH:D004892 Erythema Multiforme PMID:19040509
MESH:D005767 Gastrointestinal Diseases PMID:10596735; PMID:2258378; PMID:9832348
MESH:D006212 Hallucinations PMID:11210406; PMID:15096091; PMID:9864082
MESH:D006261 Headache PMID:10596735; PMID:10732656; PMID:8617705
MESH:D006417 Hematuria PMID:16337893
MESH:D006469 Hemoptysis PMID:16337893
MESH:D006948 Hyperkinesis PMID:10367561
MESH:D007006 Hypogonadism PMID:29850907
MESH:D007010 Hyponatremia PMID:8166325; PMID:8804257
MESH:D007024 Hypotension, Orthostatic PMID:8840377
MESH:D007172 Erectile Dysfunction PMID:9892316
MESH:D007177 Inappropriate ADH Syndrome PMID:18072985; PMID:8166325
MESH:D007319 Sleep Initiation and Maintenance Disorders PMID:10363731
MESH:D007333 Insulin Resistance PMID:17728140
MESH:D008064 Lipidoses PMID:17567588; PMID:28551711
MESH:D008178 Lupus Erythematosus, Cutaneous PMID:19040509
MESH:D008881 Migraine Disorders PMID:11589524; PMID:16342007
MESH:D009069 Movement Disorders PMID:11816261
MESH:D009128 Muscle Spasticity PMID:10084445
MESH:D009207 Myoclonus PMID:11436961; PMID:12633152; PMID:15707818; PMID:9048728
MESH:D009230 Myxedema PMID:19934393
MESH:D009325 Nausea PMID:10363731; PMID:10732656; PMID:3045113; PMID:9448656
MESH:D010292 Paresthesia PMID:18004152
MESH:D010302 Parkinson Disease, Secondary PMID:8659626
MESH:D011317 Priapism PMID:17327965; PMID:7884031
MESH:D011654 Pulmonary Edema PMID:19782326
MESH:D012148 Restless Legs Syndrome PMID:18468624
MESH:D012640 Seizures PMID:10900533; PMID:18582188
MESH:D012735 Sexual Dysfunction, Physiological PMID:11235924; PMID:15322407
MESH:D013262 Stevens-Johnson Syndrome PMID:25811541
MESH:D013375 Substance Withdrawal Syndrome PMID:7726327
MESH:D013610 Tachycardia PMID:15707818
MESH:D013981 Tic Disorders PMID:15812270
MESH:D014202 Tremor PMID:11210406
MESH:D014549 Urinary Incontinence PMID:11147747; PMID:12138594
MESH:D015431 Weight Loss PMID:10363731
MESH:D015746 Abdominal Pain PMID:8166325
MESH:D015875 Anisocoria PMID:7819940
MESH:D016055 Urinary Retention PMID:17089079; PMID:9868574
MESH:D016464 Lysosomal Storage Diseases PMID:28551711
MESH:D016584 Panic Disorder PMID:10895401; PMID:19954091
MESH:D016757 Death, Sudden, Cardiac PMID:11485134
MESH:D017109 Akathisia, Drug-Induced PMID:24568368
MESH:D019964 Mood Disorders PMID:15610935
MESH:D020018 Sexual Dysfunctions, Psychological PMID:10363731; PMID:10596735; PMID:10830148; PMID:14742097; PMID:15514423; PMID:7573593; PMID:8567191; PMID:9054202; PMID:9292833; PMID:9448656; PMID:9509375
MESH:D020186 Sleep Bruxism PMID:11157444
MESH:D020187 REM Sleep Behavior Disorder PMID:20672438
MESH:D020230 Serotonin Syndrome PMID:11816261; PMID:12456895; PMID:15707818; PMID:8195456; PMID:8869767; PMID:9048728
MESH:D020734 Parkinsonian Disorders PMID:15968847; PMID:9660102
MESH:D028361 Mitochondrial Diseases PMID:22387747
MESH:D053206 Nocturnal Enuresis PMID:16415720; PMID:17630870
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:10048942; PMID:15930079; PMID:22387747
MESH:D058186 Acute Kidney Injury PMID:15707818

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.